investors.biolifesolutions.com investors.biolifesolutions.com

investors.biolifesolutions.com

Welcome

About BioLife Solutions: The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death.  BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and

http://investors.biolifesolutions.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.BIOLIFESOLUTIONS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.5 out of 5 with 6 reviews
5 star
4
4 star
1
3 star
1
2 star
0
1 star
0

Hey there! Start your review of investors.biolifesolutions.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.7 seconds

FAVICON PREVIEW

  • investors.biolifesolutions.com

    16x16

CONTACTS AT INVESTORS.BIOLIFESOLUTIONS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Welcome | investors.biolifesolutions.com Reviews
<META>
DESCRIPTION
About BioLife Solutions: The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death.  BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and
<META>
KEYWORDS
1 info@biolifesolutions com
2 menu
3 cryostor
4 cryostor cs10
5 cryostor cs5
6 cryostor cs2
7 hypothermosol
8 hypothermosol frs
9 hypothermosol for hair
10 prepastor
CONTENT
Page content here
KEYWORDS ON
PAGE
info@biolifesolutions com,menu,cryostor,cryostor cs10,cryostor cs5,cryostor cs2,hypothermosol,hypothermosol frs,hypothermosol for hair,prepastor,bloodstor,bloodstor 27,cell thawing media,all products,biologistex,evidence,resource links,resources,blog,blfs
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Welcome | investors.biolifesolutions.com Reviews

https://investors.biolifesolutions.com

About BioLife Solutions: The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death.  BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and

INTERNAL PAGES

investors.biolifesolutions.com investors.biolifesolutions.com
1

Management Bios

http://investors.biolifesolutions.com/aby-mathew

1 866 424 6543. 10% Dextran 40 (in 0.9% NaCl). 10% Dextran 40 (in 5% Dextrose). Quality and Regulatory Systems. Master File Request Form. Aby J Mathew, Ph.D. Senior Vice President and Chief Technology Officer. 3303 Monte Villa Parkway,. Bothell, WA 98021. 1 -866 -424 -6543. 1 -425 -402 -1433. January 10 @ 1:00 am. BioLifeSolutions, Inc 2017.

2

Press Releases

http://investors.biolifesolutions.com/news-releases

1 866 424 6543. 10% Dextran 40 (in 0.9% NaCl). 10% Dextran 40 (in 5% Dextrose). Quality and Regulatory Systems. Master File Request Form. These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Mar 02, 2017. Jan 12, 2017. BioLife Solutions Announces 2016 Revenue Growth of 28%. Jan 10, 2017. Jan 03, 2017. BioLife Solutions, ...

3

Welcome

http://investors.biolifesolutions.com/welcome

1 866 424 6543. 10% Dextran 40 (in 0.9% NaCl). 10% Dextran 40 (in 5% Dextrose). Quality and Regulatory Systems. Master File Request Form. The Company’s proprietary HypoThermosol. Q4 2016 BioLife Solutions, Inc. Earnings Conference Call. Thursday, March 9, 2017. 1:30pm - 2:30pm PST. About BioLife Solutions Addressable Markets. In July 2015, Frost and Sullivan forecasted that the stem cell therapy market is expected to be worth $40 billion by 2020 and $180 billion by 2030. Read about our markets:. BioLife ...

4

Governance

http://investors.biolifesolutions.com/corporate-governance

1 866 424 6543. 10% Dextran 40 (in 0.9% NaCl). 10% Dextran 40 (in 5% Dextrose). Quality and Regulatory Systems. Master File Request Form. Governance and Nominating Committee Charter. BioLife Solutions - Amended Restated Bylaws. Mar 02, 2017. BioLife Solutions to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Business Update on March 9, 2017. Jan 12, 2017. BioLife Solutions Announces 2016 Revenue Growth of 28%. Jan 10, 2017. BioLife Solutions Amends Existing Credit Facility.

5

Investor Relations | Biolife Solutions - Financials

http://investors.biolifesolutions.com/financials

1 866 424 6543. 10% Dextran 40 (in 0.9% NaCl). 10% Dextran 40 (in 5% Dextrose). Quality and Regulatory Systems. Master File Request Form. Average Volume (10 days). Qtrly Dividend (Ann. Yield). Director, Ten Percent Owner. Jan 13, 2017. Jan 13, 2017. Andrew G. Hinson. Jan 13, 2017. Jan 13, 2017. Chief Tech. Officer and Sr. VP. Mar 15, 2016. Mar 03, 2017. Feb 16, 2017. Feb 09, 2017. Feb 09, 2017. Feb 09, 2017. Quote data delayed by at least 15 minutes. Earnings and Analyst data provided by Zacks.

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL PAGES IN THIS WEBSITE

16

LINKS TO THIS WEBSITE

biolifesolutions.com biolifesolutions.com

BioPreservation Today - Quarterly Magazine | BioLife Solutions

http://www.biolifesolutions.com/biopreservation-today

1 866 424 6543. 10% Dextran 40 (IN 0.9% NaCl). 10% Dextran 40 (IN 5% Dextrose). Quality & Regulatory Systems. Master File Request Form. 2016: Spring: Volume 6; Issue 1. ESTABLISHING BEST PRACTICE QUALIFICATION METRICS FOR SMART SHIPPING CONTAINERS. 2015: Fall: Volume 5; Issue 2. Digital Integration of the Supply. Chain Boosts Support of Advanced Therapy Products. Are Cryopreserved Platelets Just Around the Corner? Meet the BioLife Solutions Scientific Team. 2015: Winter: Volume 5; Issue 1. Biolife Soluti...

biolifesolutions.com biolifesolutions.com

Products Archive | BioLife Solutions

http://www.biolifesolutions.com/cgmp-biopreservation-media-products/polymeric-syringes

1 866 424 6543. 10% Dextran 40 (IN 0.9% NaCl). 10% Dextran 40 (IN 5% Dextrose). Quality & Regulatory Systems. Master File Request Form. 47; All Products. Sort by Default Order. Sort by Default Order. BloodStor 100 Biopreservation Media. Ndash; $72.00. BloodStor 100 Biopreservation Media. BloodStor 100 contains 100% USP grade DMSO and is packaged in 50 mL and 100 mL vials. BloodStor 100 Product Information Sheet (PDF). BloodStor 55-5 Biopreservation Media. Ndash; $2,500.00. Ndash; $340.00. BioLife’s Cell ...

biolifesolutions.com biolifesolutions.com

2015 International Cord Blood Symposium | BioLife Solutions

http://www.biolifesolutions.com/cell-therapy/events/2015-international-cord-blood-symposium

1 866 424 6543. 10% Dextran 40 (IN 0.9% NaCl). 10% Dextran 40 (IN 5% Dextrose). Quality & Regulatory Systems. Master File Request Form. 2015 International Cord Blood Symposium. 2015 International Cord Blood Symposium. 2015 International Cord Blood Symposium. June 11-13, 2015. San Francisco, CA. BioLife’s Senior Vice President and Chief Technology Officer, Aby J. Mathew, Ph.D., serves on the Planning Committee for the Scientific Program, and will serve as panel moderator for. Go to event site. 1 -866 -424...

biolifesolutions.com biolifesolutions.com

Cell Thawing Media | BioLife Solutions

http://www.biolifesolutions.com/cgmp-biopreservation-media-products/new-cell-thawing-media-10-dextran-40

1 866 424 6543. 10% Dextran 40 (IN 0.9% NaCl). 10% Dextran 40 (IN 5% Dextrose). Quality & Regulatory Systems. Master File Request Form. Cell Thawing Media 10% Dextran 40. Cell Thawing Media 10% Dextran 40 (in 0.9% NaCl). Cell Thawing Media 10% Dextran 40 (in 0.9% NaCl) provides Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. 10% Dextran 40 (in 0.9% NaCl) Product Information Sheet (PDF). Cell Thawing Media 10% Dextran 40 (in 5% Dextrose).

biolifesolutions.com biolifesolutions.com

ISCT 2015 Annual Meeting | BioLife Solutions

http://www.biolifesolutions.com/cell-therapy/events/isct-2015-annual-meeting

1 866 424 6543. 10% Dextran 40 (IN 0.9% NaCl). 10% Dextran 40 (IN 5% Dextrose). Quality & Regulatory Systems. Master File Request Form. ISCT 2015 Annual Meeting. ISCT 2015 Annual Meeting. ISCT 2015 Annual Meeting. ISCT 2015: Coming of Age. Driving Clinical Advances in Cell Therapy. Caesars Palace, Las Vegas. May 27-30, 2015. ISCT is a global association dedicated to driving the translation of scientific research aimed at delivering innovative cellular therapies to patients. It is the only group focus...

UPGRADE TO PREMIUM TO VIEW 26 MORE

TOTAL LINKS TO THIS WEBSITE

31

SOCIAL ENGAGEMENT



OTHER SITES

investors.bigmobile.com investors.bigmobile.com

Big Mobile. Investor Site

Investing in Big Mobile is a rare opportunity to buy one of the last truly independent mobile advertising companies and gain an immediate footprint across South-east Asia using proven platforms and capability, driven by a world class, business-savvy management team. Leverages partnerships with the biggest and best Mobile Publishers and MNO's in our markets with total reach estimated to be in excess of 200 million. Our management team regularly present at international digital speaking events and are key ...

investors.bigplayscoring.com investors.bigplayscoring.com

Investors Login | Big Play Scoring

Please fill in a valid value for all required fields. Please ensure all values are in a proper format. Are you sure you want to leave this form and resume later? You must upload one of the following file types for the selected field:. There was an error displaying the form. Please copy and paste the embed code again. Everyone Loves Big Plays. Interested in playing the game? Don’t watch from the sidelines. Apply to be a beta tester,. And we’ll let you know the next available time to join.

investors.biocartis.com investors.biocartis.com

Biocartis

Board of Directors and Specialist Committees. Disclosure of Outstanding Voting Securities. June 30, 2015. Biocartis’ KRAS Mutation Test receives CE-IVD marking. June 24, 2015. June 3, 2015. May 22, 2015. H1 2015 financial results. Full year 2015 financial results. Financial and Other Documents. April 28, 2015. IFRS Financial Statements 2014. June 4, 2015. 32 15 632 600. Generaal De Wittelaan 11 B3. Phone: 32 15 632 600.

investors.biogen.com investors.biogen.com

Biogen Investors |

Committee Composition and Charters. GAAP to Non-GAAP Reconciliation. Annual and Quarterly Reports. Committee Composition and Charters. Financial Information and Filings. GAAP to Non-GAAP Reconciliation. Annual and Quarterly Reports. Sign up for Alerts. Committee Composition and Charters. Here we share with you the composition of our Board of Directors. And its committees, the guidelines and charters. Code of Business Conduct: Values in Action. Explore our Code of Business Conduct: Values in Action.

investors.biohitechglobal.com investors.biohitechglobal.com

Test Page for the Nginx HTTP Server on the Amazon Linux AMI

On the Amazon Linux AMI! This page is used to test the proper operation of the nginx. HTTP server after it has been installed. If you can read this page, it means that the web server installed at this site is working properly. This is the default. Page that is distributed with nginx. On the Amazon Linux AMI. It is located in. You should now put your content in a location of your choice and edit the. Configuration directive in the nginx.

investors.biolifesolutions.com investors.biolifesolutions.com

Welcome

1 866 424 6543. 10% Dextran 40 (in 0.9% NaCl). 10% Dextran 40 (in 5% Dextrose). Quality and Regulatory Systems. Master File Request Form. The Company’s proprietary HypoThermosol. Q3 2016 BioLife Solutions, Inc. Earnings Conference Call. Thursday, November 10, 2016. 1:30pm - 2:30pm PST. BioLife Solutions to Present at 4th Annual European Advanced Therapies Investor Day. Thursday, November 3, 2016. BioLife Solutions to Present at 28th Annual ROTH Conference. About BioLife Solutions Addressable Markets.

investors.biomarcare.com investors.biomarcare.com

Investors - BioMarCare Technologies

Tooltip with colors set. ONE PAGER BioMarCare Technologies is a portfolio company of Micromedic Technologies Ltd. (TASE: MCTC) and HBL - Hadasit Bio-Holdings (TASE: HDST) - a subsidiary of Hadasit Ltd., the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. The company initiated operations in Q3/2009 and is based in Israel. The company is currently seeking a strategic alliance and/or investment funding of $2M for clinical studies and product development.

investors.biotapharma.com investors.biotapharma.com

Investor Relations - Biota Pharmaceuticals, Inc.

Please select your page. Respiratory Syncytial Virus (RSV). Please select your page. Â Board of Directors. Â Human Rhinovirus (HRV). Â Respiratory Syncytial Virus (RSV). Biota Pharmaceuticals is focused on the discovery and development of direct-acting antivirals to treat infections that affect a significant number of patients globally. The Company has four product candidates in development that address viral infections that have limited therapeutic options. 005 (- 2.10%). 4:00 PM ET on Aug 14, 2015.

investors.biz investors.biz

investors.biz -&nbspThis website is for sale! -&nbspinvestors Resources and Information.

investors.bjornborg.com investors.bjornborg.com

Björn Borg - Björn Borg

investors.bjsrestaurants.com investors.bjsrestaurants.com

Investor Relations | BJ's Restaurant and Brewhouse

BJ's Restaurant and Brewhouse. See more social options. BJ's Gifts and Gear. Q2 2015 BJ's Restaurants, Inc. Earnings Conference Call. 160;at 2:00 pm PT. 160; 0.03. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. BJ's Restaurants Opens in Murfreesboro, Tennessee. BJ's Restaurants, Inc. Reports Fiscal Second Quarter Results. BJ's Restaurants Opens in Melbourne, Florida. There are currently no events scheduled. 2014 Annual Report (Interactive Version).